A Phase I Study of Sunitinib in Combination With S-1 and Cisplatin in Patients With Advanced or Metastatic Gastric Cancer.

Trial Profile

A Phase I Study of Sunitinib in Combination With S-1 and Cisplatin in Patients With Advanced or Metastatic Gastric Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Mar 2015

At a glance

  • Drugs Sunitinib (Primary) ; Cisplatin; Gimeracil/oteracil/tegafur
  • Indications Gastric cancer
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 06 Mar 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 21 Jan 2014 Planned End Date changed from 1 Mar 2014 to 1 Mar 2015 as per ClinicalTrials.gov record.
    • 01 Jul 2013 Planned end date changed from 1 Sep 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top